The Glazer Capital, LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison
Ava Hoppe | 10 May, 2023
Investment firms that manage more than $100 million in assets are required to file a quarterly report known as the 13F with the SEC. The report details the company's holdings of publicly-traded securities such as stocks and options.
One such company that recently filed its 13F report is Glazer Capital, LLC. The report shows the company's holdings for Q3 2022 compared to Q4 2022.
Glazer Capital, LLC is a New York-based hedge fund with over $2 billion in assets under management. According to the report, the company held positions in 44 companies as of December 31, 2022.
The report reveals that Glazer Capital increased its holdings in several companies during Q4 2022. For example, the company increased its holdings in ARES ACQUISITION CORPORATION from 9,985,000 shares to 12,965,873 shares, a 31.7% change. Likewise, Glazer Capital increased its holdings in VECTOR ACQUISITION CORP II by 1.6% to 4,455,718 shares.
However, the report also shows that Glazer Capital reduced its holdings in some companies during Q4 2022. For example, the company reduced its holdings in FRONTIER ACQUISITION CORP by 7.6% to 2,191,435 shares. Additionally, the company reduced its holdings in INFINT ACQUISITION CORP by 3.5% to 1,947,475 shares.
Overall, the report shows that Glazer Capital remains an active player in the market, with a diverse portfolio of holdings. It will be interesting to see how the company's holdings change in the coming quarters, and what the company's investment strategies will be in the future.
Other Posts
- CX Institutional Fund's Q3 2022 vs. Q4 2022 Holdings Comparison: Insights on Stock and Bond ETFs Investments
- Western Asset Management Company, LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Navigating the Shifts: Dynamic Advisor Solutions' Investment Strategy Evolution from Q4 2023 to Q1 2024
- Tracking Permanens Capital's Shift in Portfolio Holdings from Q3 to Q4 2022
- WESPAC Advisors, LLC Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Cosette Pharmaceuticals Launches Dapsone 5% Gel: An Affordable Acne Treatment Alternative
- Fabcon Precast Expands Its Geographic Footprint with Bristol Precast Acquisition
- Urologic Specialists Joins Solaris Health, Expanding National Healthcare Platform
- West Oak Capital, LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Navigating the Waters of Investment: A Deep Dive into SOL Capital Management's Strategic Shifts from Q4 2023 to Q1 2024